FLT3 and acute myeloid leukemia: In addition, it was recently described that patients with FLT3-ITD mutation present with dysregulated serine metabolism and inhibition of de novo serine synthesis, most likely through decrease in purine synthesis for which serine is a physiological precursor, decreases proliferation of FLT3-ITD mutated AML cells and increases their sensitivity to cytarabine (26).